MSOS:NYE-AdvisorShares Pure US Cannabis ETF (USD)

ETF | Others |

Last Closing

USD 7.07

Change

0.00 (0.00)%

Market Cap

USD 0.89B

Volume

6.25M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing MSOS

YOLO AdvisorShares Pure Cannab.. 45.31 % 0.00 %

N/A

USD 0.04B
BUDX 23.56 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.86% 15% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.86% 15% F 30% F
Trailing 12 Months  
Capital Gain -10.96% 6% D- 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.96% 6% D- 19% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -21.06% N/A N/A 3% F
Dividend Return -21.06% N/A N/A 3% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.40% N/A N/A 23% F
Risk Adjusted Return -50.86% N/A N/A 5% F
Market Capitalization 0.89B 88% B+ 55% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike